Patient Unique Stigmatization Holistic tool in dermatology (PUSH-D): Development and validation of a dermatology-specific stigmatization assessment tool.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
06
05
2022
accepted:
13
09
2022
pubmed:
7
10
2022
medline:
18
1
2023
entrez:
6
10
2022
Statut:
ppublish
Résumé
The skin plays an important role in establishing interpersonal relationships, and thus visible skin disorders, which have a significant impact on physical appearance, influence other people's behaviours and attitudes. To develop and validate a dermatologic-specific questionnaire to evaluate stigmatization in individuals with visible skin conditions. Items were generated by a verbatim report based on qualitative interviews with patients with various dermatologic conditions. Subsequently, a study was implemented for psychometric analysis. A dermatology-specific stigmatization questionnaire (PUSH-D) was refined via item reduction according to inter-question correlations, consensus among experts and exploratory factor analysis. Internal consistency was determined by calculating Cronbach's α. Concurrent validity was determined by calculating the correlation between PUSH-D and the Dermatology Life Quality Index (DLQI) and the Rosenberg Self-Esteem Scale (RSES). From a primary list of 22 items, PUSH-D was reduced to a 17-item questionnaire, covering two pertinent dimensions based on the exploratory factor analysis. Construct validity was demonstrated, and PUSH-D showed good internal consistency (Cronbach's α = 0.9). PUSH-D correlated strongly with the DLQI 0.72 (p < 0.001) and moderately with the RSES 0.49 (p < 0.001). PUSH-D allows a comprehensive view of the degree of stigmatization in visible skin disorders, as well as the comparability of stigmatization levels across various skin conditions.
Sections du résumé
BACKGROUND
BACKGROUND
The skin plays an important role in establishing interpersonal relationships, and thus visible skin disorders, which have a significant impact on physical appearance, influence other people's behaviours and attitudes.
OBJECTIVE
OBJECTIVE
To develop and validate a dermatologic-specific questionnaire to evaluate stigmatization in individuals with visible skin conditions.
METHODS
METHODS
Items were generated by a verbatim report based on qualitative interviews with patients with various dermatologic conditions. Subsequently, a study was implemented for psychometric analysis. A dermatology-specific stigmatization questionnaire (PUSH-D) was refined via item reduction according to inter-question correlations, consensus among experts and exploratory factor analysis. Internal consistency was determined by calculating Cronbach's α. Concurrent validity was determined by calculating the correlation between PUSH-D and the Dermatology Life Quality Index (DLQI) and the Rosenberg Self-Esteem Scale (RSES).
RESULTS
RESULTS
From a primary list of 22 items, PUSH-D was reduced to a 17-item questionnaire, covering two pertinent dimensions based on the exploratory factor analysis. Construct validity was demonstrated, and PUSH-D showed good internal consistency (Cronbach's α = 0.9). PUSH-D correlated strongly with the DLQI 0.72 (p < 0.001) and moderately with the RSES 0.49 (p < 0.001).
CONCLUSION
CONCLUSIONS
PUSH-D allows a comprehensive view of the degree of stigmatization in visible skin disorders, as well as the comparability of stigmatization levels across various skin conditions.
Identifiants
pubmed: 36201355
doi: 10.1111/jdv.18641
pmc: PMC10092236
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
443-450Subventions
Organisme : Cosmetic Active International
Organisme : Lilly France
Informations de copyright
© 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1493-1504
pubmed: 33428316
J Investig Dermatol Symp Proc. 2004 Mar;9(2):169-80
pubmed: 15083785
BMC Public Health. 2013 Apr 04;13:298
pubmed: 23556435
Body Image. 2007 Mar;4(1):79-86
pubmed: 18089254
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
Adv Clin Exp Med. 2019 Jun;28(6):825-832
pubmed: 30740941
JAMA Dermatol. 2021 Apr 1;157(4):392-398
pubmed: 33688916
Disabil Rehabil. 2006 Feb 28;28(4):193-203
pubmed: 16467054
J Plast Reconstr Aesthet Surg. 2008 Sep;61(9):1049-58
pubmed: 18617450
Sociol Health Illn. 2009 Apr;31(3):441-55
pubmed: 19366430
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Br J Dermatol. 2008 Jan;158(1):101-8
pubmed: 17999699
JAMA Dermatol. 2020 Aug 1;156(8):874-881
pubmed: 32520352
Psychometrika. 1951 Jun;16(2):167-88
pubmed: 14844557
BMC Med. 2019 Feb 15;17(1):13
pubmed: 30764817
J Cutan Med Surg. 2010 Nov-Dec;14(6):285-90
pubmed: 21084021
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):443-450
pubmed: 36201355
Hautarzt. 2003 Sep;54(9):852-7
pubmed: 12955263
Postepy Hig Med Dosw (Online). 2017 Nov 3;71(0):901-905
pubmed: 29151062
PLoS One. 2018 Sep 28;13(9):e0205009
pubmed: 30265724
J Clin Exp Neuropsychol. 1994 Feb;16(1):93-104
pubmed: 8150893
Psychol Res Behav Manag. 2014 Aug 02;7:201-12
pubmed: 25120377
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2029-2038
pubmed: 31177601
Disabil Rehabil. 2011;33(9):711-9
pubmed: 20690861
PLoS Negl Trop Dis. 2014 Nov 06;8(11):e3274
pubmed: 25376007
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1421-1428
pubmed: 30891839
Disabil Rehabil. 2012;34(19):1596-607
pubmed: 22372970
BMC Med Res Methodol. 2010 Mar 18;10:22
pubmed: 20298572
J Am Acad Dermatol. 1989 Jan;20(1):53-63
pubmed: 2913081
Psychol Assess. 2006 Mar;18(1):106-11
pubmed: 16594819
Sci Rep. 2019 May 29;9(1):8021
pubmed: 31142792
J Strength Cond Res. 2005 Feb;19(1):231-40
pubmed: 15705040
J Am Acad Dermatol. 2021 May;84(5):1432-1434
pubmed: 32574586
J Am Acad Dermatol. 2019 Jun;80(6):1556-1563
pubmed: 30171876
Value Health. 1999 Mar-Apr;2(2):113-27
pubmed: 16674343
J Eur Acad Dermatol Venereol. 2022 Apr;36(4):499-525
pubmed: 34817889
J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2202-2208
pubmed: 31087405